TScan Therapeutics, Inc. (TCRX) NASDAQ

1.09

-0.07(-6.03%)

Updated at November 07 04:00PM

Currency In USD

Valuation

Market Cap340.45M
Enterprise Value259.14M
P/E Ratio-1.03
PEG Ratio-0.01
Price/Sales Ratio8.86
Price/Book Ratio0.8
Enterprise/Revenue-6.22
Enterprise/EBITDA0.33

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-19.65
Operating Margin-20.72

Management Effectiveness

Return On Assets-0.46
Return On Equity-0.64

Income Statement

Revenue2.82M
Revenue/Share0.05
Gross Profit2.82M
EBITDA-119.74M
Net Income-127.5M
Diluted EPS-1.14

Balance Sheet

Total Cash218.05M
Total Cash/Share1.68
Total Debt64.4M
Total Debt/Equity0.36
Current Ratio7.06
Book Value Per Share1.36

Price History

52-Week Change-81.14
52-Week High5.92
52-Week Low1.02
Moving Average 50 Days1.91
Moving Average 200 Days1.75

Statistics

Average Volume551,620
Shares Outstanding56.59M
% Held by Institutions26.36

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A